Head-to-head · Cost-Efficiency Index
TRT Kingdom vs Intimate Rose
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
TRT Kingdom
Shoppers open to a TRT-focused telehealth brand's GLP-1 line who are comfortable committing to a 4-month prepay term for the advertised rate.
Visit TRT KingdomIntimate Rose
Cost-first shoppers who want existing Intimate Rose pelvic-health customers curious about its bolt-on GLP-1 program, not comparison shoppers.
Visit Intimate RoseThe verdict
TRT Kingdom takes it, leading the Cost-Efficiency Index 54 to 53. TRT Kingdom -- despite its testosterone-focused name -- runs a genuine compounded GLP-1 weight-loss line ('Compounded GLP-1' and 'Compounded GLP-1/GIP') priced at $149/month and $199/month respectively. Intimate Rose still earns a C — Cost-first shoppers who want existing Intimate Rose pelvic-health customers curious about its bolt-on GLP-1 program, not comparison shoppers.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs TRT Kingdom.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | TRT Kingdom | Intimate Rose |
|---|---|---|
| Cost-Efficiency Index | 54/100 | 53/100 |
| Semaglutide / mo | $149/mo (compounded) | $169/mo (starting dose, compounded) |
| Tirzepatide / mo | $199/mo (compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $1,788 | $2,028 |
| Tirzepatide / yr (modeled) | $2,388 | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #365 | #368 |
TRT Kingdom
54/100Where the value is
- Confirmed, real compounded GLP-1 (semaglutide) and GLP-1/GIP (tirzepatide) products exist and are separately priced, despite the company's TRT-focused branding
- Named clinical group and Chief Medical Officer (REM Health Medical Group, P.A.; Daniel Olivero) plus two named nurse practitioners
- LegitScript verification badge displayed
The tradeoffs
- The advertised $149/$199 monthly rates require committing to a 4-month plan; no month-to-month or shorter-term price is published
- Pharmacy is described only as 'an FDA registered pharmacy in the USA' -- no name, state, or accreditation given
Intimate Rose
53/100Where the value is
- A real, working GLP-1 telehealth funnel exists (not a dead link or vaporware page)
- The quiz states 'No payment to get started', so shoppers can get a personalized quote before committing
- Backed by an established, non-fly-by-night e-commerce brand with an existing customer base and content library
The tradeoffs
- GLP-1 is a secondary bolt-on to a pelvic-health device business, not this company's core competency — no dedicated GLP-1 clinical infrastructure is visible on the public site
- Only one undifferentiated price point ($169/month) is published — no dose tiers, no separate semaglutide vs. tirzepatide pricing, no fee itemization
Regulatory note: the FDA issued a warning letter to Intimate Rose in September 2025. We still list and link to Intimate Rose; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.